Percutaneous minidose metrizamide endomyelographic computed tomography in syringomyelia.
Two patients presented with syringomyelia, each unusual. After neuroradiographic diagnosis with delayed metrizamide computed tomography (CT) or magnetic resonance imaging (MRI), an interesting diagnostic question arose. A percutaneous minidose metrizamide endomyelographic CT (PMDMECT) study clarified each situation and directly affected the neurosurgical approaches. The features of each case, the technique of PMDMECT, and postoperative follow-up data are reported.
D000279:Administration, Cutaneous; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008793:Metrizamide / Q000008:administration & dosage*; D008875:Middle Aged; D009192:Myelography; D013595:Syringomyelia / Q000000981:diagnostic imaging* / Q000601:surgery; D014057:Tomography, X-Ray Computed
D008793:Metrizamide